Patents Assigned to National University Corporation Kobe University
-
Patent number: 9056862Abstract: The present invention provides an anticancer drug having a Ras function inhibitory action. The present invention provides a Ras function inhibitor comprising a compound represented by the formula (I?): wherein each symbol is as defined in the present specification, or a salt thereof.Type: GrantFiled: May 9, 2012Date of Patent: June 16, 2015Assignees: NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, KNC LABORATORIES CO., LTD.Inventors: Tohru Kataoka, Fumi Shima, Masahiro Neya, Daisuke Sasahara
-
Patent number: 8976638Abstract: Provided is an information encoding method and a holographic memory device which increase the amount of information per page of a holographic memory and reduce the bit error rate to ensure a larger multiplexing number. The holographic memory information encoding method expresses information of signal page data in a holographic memory as a multi-stage data using different resolution by block coding, and superimposes each data on a single page of signal page data. The multi-stage data using different resolution is realized by light amplitude data and phase data. The amplitude data is divided by area through block coding. When n odd-numbered ON bits exist in a divided area of the phase data, a phase of 2?s/n (where n and s are natural numbers) is imparted as s-th phase information to one value of binary data, and the same phase is imparted to the other value of binary data.Type: GrantFiled: August 15, 2012Date of Patent: March 10, 2015Assignee: National University Corporation Kobe UniversityInventor: Osamu Matoba
-
Patent number: 8962287Abstract: An object of the present invention is to provide a cell capable of efficiently producing scyllo-inositol from myo-inositol and a simple method of manufacturing scyllo-inositol using the cell. The above-mentioned object is achieved by a Bacillus subtilis cell, in which a function of a protein having a scyllo-inositol dehydrogenase activity is lost, and the manufacture of scyllo-inositol using the cell, based on a novel finding that the protein having a scyllo-inositol dehydrogenase activity and a protein having a 2-keto-myo-inositol ketoreductase function are present in Bacillus subtilis.Type: GrantFiled: October 30, 2009Date of Patent: February 24, 2015Assignee: National University Corporation KOBE UniversityInventors: Kenichi Yoshida, Hitoshi Ashida
-
Publication number: 20150047756Abstract: Provided is an Mg alloy and a method for producing same able to demonstrate high strength without requiring an expensive rare earth element (RE). The high-strength Mg alloy containing Ca and Zn within a solid solubility limit and the remainder having a chemical composition comprising Mg and unavoidable impurities is characterized in comprising equiaxial crystal particles, there being a segregated area of Ca and Zn along the (c) axis of a Mg hexagonal lattice within the crystal particle, and having a structure in which the segregated area is lined up by Mg3 atomic spacing in the (a) axis of the Mg hexagonal lattice. The method for producing the high-strength Mg alloy is characterized in that Ca and Zn are added to Mg in a compounding amount corresponding to the above composition and, after homogenization heat treating an ingot formed by dissolution and casting, the above structure is formed by subjecting the ingot to hot processing.Type: ApplicationFiled: November 6, 2012Publication date: February 19, 2015Applicants: TOYOTA JIDOSHA KABUSHIKI KAISHA, NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, NATIONAL INSITITUTE FOR MATERIALS SCIENCEInventors: Kota Washio, Akira Kato, Toshiji Mukai, Alok Singh, Hidetoshi Somekawa
-
Patent number: 8957181Abstract: A preparation process for a cyclic conjugated polymer, includes the steps of deprotonating a monohalogenated cyclic conjugated compound of a 5- to 7-membered ring using a deprotonation catalyst comprising secondary amine represented by R1NHR2 (R1 and R2 are the same or different and are each a branched or cyclic alkyl group of 1 to 15 carbon atoms or a phenyl group) and a Grignard reagent represented by R3MgX (X is a halogen atom selected from chlorine, bromine and iodine, and R3 is a straight-chain or branched alkyl group of 1 to 6 carbon atoms) and polymerizing the deprotonated monohalogenated cyclic conjugated compound.Type: GrantFiled: May 21, 2012Date of Patent: February 17, 2015Assignees: Soken Chemical & Engineering Co., Ltd., National University Corporation Kobe UniversityInventors: Syuji Okamoto, Hikaru Meguro, Atsunori Mori
-
Publication number: 20140377156Abstract: Disclosed is a CO2 permselective membrane 1 having an amino acid ionic liquid and a porous membrane impregnated with the amino acid ionic liquid, wherein the amino acid ionic liquid contains a certain range of water.Type: ApplicationFiled: February 6, 2013Publication date: December 25, 2014Applicants: NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, RENAISSANCE ENERGY RESEARCH CORPORATIONInventors: Osamu Okada, Nobuaki Hanai, Eiji Kamio, Shohei Kasahara, Hideto Matsuyama
-
Patent number: 8873868Abstract: An apparatus is provided for classifying targets into a known-object group and an unknown-object group. The apparatus includes a speech/image data storage unit configured to store a spoken sound of a name of an object and an image of the object; a unit configured to calculate a speech confidence level of a speech for the name of the object with reference to a spoken sound of a name of a known object; a unit configured to calculate an image confidence level of an image of an object with respect to an image of a known object; and a unit configured to compare an evaluation value, which is obtained by combining the speech confidence level and image confidence level, with a threshold value, and classify a target object into an object group determined according to whether the spoken sound of the name and the image are known or unknown.Type: GrantFiled: December 21, 2012Date of Patent: October 28, 2014Assignees: Honda Motor Co. Ltd., National University Corporation Kobe UniversityInventors: Mikio Nakano, Naoto Iwahashi, Yasuo Ariki, Yuko Ozasa, Takahiro Hori, Ryohei Nakatani
-
Publication number: 20140249814Abstract: An object recognition system is applicable to practical use, and utilizes image information besides speech information to improve recognition accuracy. The object recognition system comprises a speech recognition unit to determine candidates for a result of speech recognition on input speech and their likelihoods, and an image model generation unit to generate image models of a predetermined number of the candidates having the highest likelihoods. The system further comprises an image likelihood calculation unit to calculate image likelihoods of input images based on the image models, and an object recognition unit to perform object recognition using the image likelihoods. At the time of generating the image model of the candidate, the image model generation unit first searches an image model database, and, when the image model of the candidate is not found in the database, the image model generation unit generates said image model from image information on the web.Type: ApplicationFiled: February 26, 2014Publication date: September 4, 2014Applicants: HONDA MOTOR CO., LTD., NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITYInventors: Mikio NAKANO, Hitoshi NISHIMURA, Yuko OZASA, Yasuo ARIKI
-
Patent number: 8822383Abstract: Provided is a novel compound which can germinate seeds of root parasitic plants, more specifically, a compound represented by the formula: wherein R1, R2, R3, R4, and R5 are the same or different and each represents a hydrogen atom, a halogen atom, a lower alkyl group, or a lower alkoxy group, or R1 and R2 are linked together to form a lower alkylenedioxy group, or R1 and R2 together with the adjacent carbon atoms form a benzene ring, or R2 and R3 are linked together to form a lower alkylenedioxy group, or R2 and R3 together with the adjacent carbon atoms form a benzene ring, R6 represents a hydrogen atom or a lower alkyl group, X and Y are the same or different and each represents an oxygen atom and a sulfur atom, and n represents an integer of 0, 1 or 2, and a method for controlling root parasitic plants.Type: GrantFiled: March 30, 2011Date of Patent: September 2, 2014Assignees: National University Corporation KOBE UNIVERSITY, Sumitomo Chemical Company, LimitedInventors: Mitsuru Sasaki, Yukihiro Sugimoto, Hirosato Takikawa, Hideyoshi Miyake, Noritada Matsuo
-
Publication number: 20140194412Abstract: The present invention provides an anticancer drug having a Ras function inhibitory action. The present invention provides a Ras function inhibitor comprising a compound represented by the formula (I?): wherein each symbol is as defined in the present specification, or a salt thereof.Type: ApplicationFiled: May 9, 2012Publication date: July 10, 2014Applicants: KNC LABORATORIES CO., LTD., NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITYInventors: Tohru Kataoka, Fumi Shima, Masahiro Neya, Daisuke Sasahara
-
Patent number: 8772708Abstract: An embodiment with a dual-stage reflectron is as follows: (1) On the assumption that a reflector has a base potential XA(U) created by uniform electric fields, its design parameters are adjusted so as to cancel the first and second order derivatives at energy E=E0 of a total time of flight T(E), and a second-order focusing position on a central axis at which the potential value becomes zero is determined (Mamyrin solution). (2) A correcting potential XC(U) to be superposed on XA(U), beginning from the second-order focusing position, is calculated so that T(E) of ions reflected in a region deeper than the second-order focusing position will be constant. (3) Voltage values of the reflector electrodes are determined so that a real potential XR(U)=XA(U)+XC(U) is created on the central axis.Type: GrantFiled: December 20, 2011Date of Patent: July 8, 2014Assignees: National University Corporation Kobe University, Shimadzu CorporationInventors: Tohru Kinugawa, Osamu Furuhashi
-
Publication number: 20140127120Abstract: The present invention provides a prophylactic or therapeutic agent for fracture and bone diseases as well as a bone growth promoting agent containing carbon dioxide as an active ingredient. Further, according to the present invention, an additive or synergistic effect for preventing or treating fracture and bone diseases as well as for promoting bone growth by combining the therapeutic agent of the present invention and a bone absorption inhibitor and/or a bone formation promoter is obtained.Type: ApplicationFiled: July 13, 2012Publication date: May 8, 2014Applicants: NEOCHEMIR INC., NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, CO2BE MEDICAL ENGINEERING K.K.Inventors: Keisuke Oe, Takahiro Niikura, Masahiko Miwa, Takeshi Ueha, Masaya Tanaka
-
Publication number: 20140119168Abstract: Provided is an information encoding method and a holographic memory device which increase the amount of information per page of a holographic memory and reduce the bit error rate to ensure a larger multiplexing number. The holographic memory information encoding method expresses information of signal page data in a holographic memory as a multi-stage data using different resolution by block coding, and superimposes each data on a single page of signal page data. The multi-stage data using different resolution is realized by light amplitude data and phase data. The amplitude data is divided by area through block coding. When n odd-numbered ON bits exist in a divided area of the phase data, a phase of 2?s/n (where n and s are natural numbers) is imparted as s-th phase information to one value of binary data, and the same phase is imparted to the other value of binary data.Type: ApplicationFiled: August 15, 2012Publication date: May 1, 2014Applicant: NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITYInventor: Osamu Matoba
-
Publication number: 20140120598Abstract: Provided is a novel method of producing ethanol by using a cellulose-based biomass as a raw material. In particular, provided is a novel method of producing ethanol by which ethanol can be effectively produced in the presence of a substance having an inhibitory action on fermentation of ethanol. Ethanol can be effectively produced by using a microorganism engineered to suppress the expression of at least one kind of phosphatase among the phosphatases intrinsically possessed by the microorganism, even under a condition where a substance that has heretofore been believed to have a fermentation inhibitory action, specifically, a weakly acidic substance and/or a furan compound are/is incorporated.Type: ApplicationFiled: June 25, 2012Publication date: May 1, 2014Applicant: National University Corporation KOBE UniversityInventors: Akihiko Kondo, Tomohisa Hasunuma
-
Publication number: 20140107303Abstract: A preparation process for a cyclic conjugated polymer, includes the steps of deprotonating a monohalogenated cyclic conjugated compound of a 5- to 7-membered ring using a deprotonation catalyst comprising secondary amine represented by R1NHR2 (R1 and R2 are the same or different and are each a branched or cyclic alkyl group of 1 to 15 carbon atoms or a phenyl group) and a Grignard reagent represented by R3MgX (X is a halogen atom selected from chlorine, bromine and iodine, and R3 is a straight-chain or branched alkyl group of 1 to 6 carbon atoms) and polymerizing the deprotonated monohalogenated cyclic conjugated compound.Type: ApplicationFiled: May 21, 2012Publication date: April 17, 2014Applicants: National University Corporation Kobe University, Soken Chemical & Engineering Co., Ltd.Inventors: Syuji Okamoto, Hikaru Meguro, Atsunori Mori
-
Patent number: 8687864Abstract: An image diagnostic processing device includes peripheral region specifying means which specifies a peripheral region connecting to an abnormal candidate region included in an image representing the inside of a subject, and judging means which judges whether the abnormal candidate region is an anatomic abnormal region or not, based on a first feature quantity of the abnormal candidate region and a second feature quantity of the peripheral region.Type: GrantFiled: January 13, 2012Date of Patent: April 1, 2014Assignees: National University Corporation Kobe University, Toshiba Medical Systems CorporationInventors: Sumiaki Matsumoto, Hitoshi Yamagata
-
Publication number: 20140081584Abstract: A distribution analysis device analyzes a distribution of a field having a property satisfying the Laplace equation, and includes: an obtainment unit that obtains measurement data indicating the distribution of the field measured through a sensor sensing area, the sensor sensing area being an area that moves in a measurement area where the distribution of the field is measured and being an area in which the field is sensed as an aggregate; and a calculation unit that calculates analysis data indicating the distribution of the field with a higher resolution than the measurement data, using an arithmetic expression that is obtained by deriving a solution of the Laplace equation using a boundary condition that an integral of the solution of the Laplace equation in a finite interval corresponding to a size of the sensor sensing area matches the measurement data.Type: ApplicationFiled: May 1, 2012Publication date: March 20, 2014Applicant: National University Corporation Kobe UniversityInventor: Kenjiro Kimura
-
Publication number: 20140024123Abstract: Provided is a screening method for a more effective Ras inhibitor. Further provided are amino acid residues at a site important for an interaction with a Ras inhibitor in a Ras polypeptide. By confirming a difference between structural information on the Ras polypeptide by NMR and structural information between a complex of the Ras polypeptide and a seed compound by NMR, a more effective lead compound than the seed compound can be selected. As a result of analysis based on the structural information on the Ras polypeptide by NMR, the amino acid residues capable of interacting with a Ras inhibitor candidate (a) are K5, E37, D38, S39, L56, E63, Y64, A66, M67, Q70, Y71, R73, and T74 with reference to an amino acid sequence set forth in SEQ ID NO: 1.Type: ApplicationFiled: January 31, 2012Publication date: January 23, 2014Applicant: NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITYInventors: Tohru Kataoka, Fumi Shima, Atsuo Tamuta, Mitsugu Araki
-
Publication number: 20140017651Abstract: Provided is a method for manufacturing a three-dimensional molded model that can reproduce the feel of an organ. A three-dimensional shape of a body site subject to molding is extracted from brightness information of two-dimensional data obtained from medical diagnostic devices, and three-dimensional molding data of the body site and the internal structure site thereof is created. The three-dimensional shape data is edited using a modeling function. Respective touch equivalent parameter tables are created. The material type and the formulation ratio of the modeling material used for molding each body site and internal structural site are defined, and added to the touch equivalent parameter tables. Primitive shape data is generated from the parameters of the touch equivalent parameter tables, and a Boolean operation is performed on the body site data and internal structure site data as well as on the primitive shape data. Molding is performed using the defined materials.Type: ApplicationFiled: March 30, 2012Publication date: January 16, 2014Applicants: FASOTEC CO., LTD., NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITYInventors: Maki Sugimoto, Takeshi Azuama, Kinichi Watanabe, Shukichi Shimada
-
Publication number: 20140017157Abstract: An antitumor agent comprising carbon dioxide as an active ingredient of the present invention can reduce the tumor volume or eradicate the tumor of a patient who is difficult to take a surgical therapy, a chemotherapy, a radiation therapy or an immunotherapy. The antitumor agent comprising carbon dioxide as an active ingredient of the present invention is useful because the agent enables (1) the reduction in size or elimination of a tumor, (2) the suppression of tumor metastasis and also (3) the reduction in volume or elimination of a tumor at a part different from the part where carbon dioxide is transdermally absorbed by the transdermal absorption of carbon dioxide through the skin near the tumor or the skin far from the tumor.Type: ApplicationFiled: March 22, 2012Publication date: January 16, 2014Applicants: NEOCHEMIR INC., NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, CO2BE MEDICAL ENGINEERING K.K.Inventors: Toshihiro Akisue, Masahiko Miwa, Takeshi Ueha, Masaya Tanaka